Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $18,320 - $20,501
-101 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$187.49 - $221.1 $2,062 - $2,432
-11 Reduced 9.82%
101 $20,000
Q1 2021

May 13, 2021

BUY
$207.02 - $241.31 $4,347 - $5,067
21 Added 23.08%
112 $24,000
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $1,242 - $1,656
-6 Reduced 6.19%
91 $22,000
Q2 2020

Aug 04, 2020

BUY
$225.48 - $295.8 $3,156 - $4,141
14 Added 16.87%
97 $28,000
Q4 2019

Jan 28, 2020

SELL
$166.71 - $223.91 $833 - $1,119
-5 Reduced 5.68%
83 $18,000
Q3 2019

Oct 31, 2019

BUY
$166.23 - $187.09 $5,319 - $5,986
32 Added 57.14%
88 $15,000
Q2 2019

Jul 30, 2019

BUY
$164.61 - $190.37 $1,646 - $1,903
10 Added 21.74%
56 $10,000
Q1 2019

Apr 26, 2019

BUY
$163.73 - $194.7 $1,146 - $1,362
7 Added 17.95%
46 $8,000
Q4 2018

Jan 25, 2019

SELL
$151.91 - $192.21 $759 - $961
-5 Reduced 11.36%
39 $6,000
Q3 2018

Oct 26, 2018

BUY
$167.73 - $192.74 $838 - $963
5 Added 12.82%
44 $8,000
Q2 2018

Jul 27, 2018

SELL
$145.72 - $169.96 $3,788 - $4,418
-26 Reduced 40.0%
39 $7,000
Q1 2018

Apr 27, 2018

BUY
$151.6 - $177.13 $3,941 - $4,605
26 Added 66.67%
65 $11,000
Q4 2017

Jan 26, 2018

SELL
$137.28 - $155.55 $4,392 - $4,977
-32 Reduced 45.07%
39 $6,000
Q3 2017

Oct 27, 2017

BUY
$148.13 - $162.24 $10,517 - $11,519
71
71 $11,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.